News
AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.
Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...
Led by Robert Bone, PhD, assistant professor at the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), the ...
Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.
Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...
Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.
Revvity serves the pharmaceutical and biotech industries, diagnostic labs, academia. and governments in more than 160 ...
AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results